Agnès Lemarchand
Director/Board Member at SAINT-GOBAIN
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Sophie Zurquiyah-Rousset | F | 57 | 11 years | |
Pierre-André de Chalendar | M | 66 | 35 years | |
Benoît Bazin | M | 54 | 25 years | |
Marie-Paule Kieny | F | 68 |
bioMERIEUX Benelux SANV
bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | 7 years |
Pierre Gurdjian | M | 63 | 2 years | |
Pierre Boulud | M | 52 | 8 years | |
Fanny Letier | F | 45 |
bioMERIEUX Benelux SANV
bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | 7 years |
Carolle Foissaud | F | 57 | 11 years | |
Christiaan Jansen | M | - |
bioMERIEUX Benelux SANV
bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | - |
Benoit d'Iribarne | M | 62 | - | |
Ulrike Steinhorst | F | 72 | 11 years | |
Ieda Gomes Yell | F | 66 | 8 years | |
Christoph Büren | M | - |
Vivescia SCA
Vivescia SCA Miscellaneous Commercial ServicesCommercial Services Vivescia SCA operates as an agricultural cooperative company. Its members include producers of cereal, malt, and wheat. The company was founded in 1921 and is headquartered in Reims, France. | 10 years |
Yvette M. Dominique Leroy | F | 63 | - | |
Lisa Brown | F | 46 | 1 years | |
Aude Thibaut de Maisières | F | 49 | 4 years | |
Hovey Cox | M | - | 10 years | |
Sreedhar Natarajan | M | 54 | 30 years | |
Frédéric Besème | M | 67 |
bioMERIEUX Benelux SANV
bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | 6 years |
Mike Daly | M | 70 | 9 years | |
Jana Revedin | F | - | 1 years | |
Pamela Knapp | F | 66 | 11 years | |
Alain Mérieux | M | 85 |
bioMERIEUX Benelux SANV
bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | 7 years |
Antoine Vignial | M | 62 | 12 years | |
Gilles Schnepp | M | 64 | 15 years | |
Wolfgang Colberg | M | 64 | 3 years | |
Thierry Delaporte | M | 57 | 2 years | |
Yves-René Nanot | M | 87 | 31 years | |
Jean-François Cirelli | M | 65 | 4 years | |
Guillaume Bouhours | M | 47 | 6 years | |
Alexandre Mérieux | M | 50 |
bioMERIEUX Benelux SANV
bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | 20 years |
Véronique Boca | F | - | 13 years | |
Jean-Dominique Senard | M | 71 | 12 years | |
Claire Pédini | F | 58 | 14 years | |
Gonzague de Pirey | M | 50 | 17 years | |
Mark van Bijsterveld | M | 55 | 1 years | |
Philippe Thibaudet | M | 43 | 6 years | |
Lanny Duvall | M | 56 | 1 years | |
Christian Bako | M | 42 | 1 years | |
Sibylle Daunis Opfermann | F | 49 | 4 years | |
Chu Ong Ting | M | - | 9 years | |
Noemie Chocat | F | - | 3 years | |
Anne Hardy | F | - | 3 years | |
Alix Sicaud | M | - | 3 years | |
Ursula Soritsch-Renier | F | 57 | 3 years | |
Patrick Edouard Dupin | M | 61 | - | |
David Eric Molho | M | - | - | |
Philippe Kehren | M | 53 | 1 years | |
Lydie Cortes | F | - | - | |
Giampiero Pesenti | M | 93 | 32 years | |
Harold Y. H. Boël | M | 59 |
bioMERIEUX Benelux SANV
bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | 12 years |
Jean-François Phelizon | M | 78 | 35 years | |
Marie-Hélène Habert-Dassault | F | 59 |
bioMERIEUX Benelux SANV
bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | 12 years |
Delphine de Sahuguet d'Amarzit | F | 51 |
Banque Publique d'Investissement
Banque Publique d'Investissement Finance/Rental/LeasingFinance Banque Publique Dinvestissement (Bpifrance) is the French Government's public investment institution which was created in 2013 to 'serve the future' by providing financing solutions tailored to each stage of a company's life. Located in Maisons-Alfort, Bpifrance aims to invest EUR 12 billion in French companies by 2017. Their three main tasks are: to help overcome market failures that hamper the financing of enterprises, especially SMEs; to invest in the development of strategic sectors such as digital conversion, environmental and energy, and the social and solidarity economy; and to act as a lever to develop territories in connection with regions in France. Bpifrance includes OSEO, CDC Entreprises, FSI and FSI Regions. OSEO is a public institution whose mission is to support innovation and growth of SMEs. CDC Entreprises is a management company that invests directly or indirectly in SMEs and ETIs at all stages of their development. FSI is an investment fund established by the French government in 2008 to help French companies seeking stable investors to finance their development projects and FSI Régions is a management company which provides regional investment capital. In 2013, OSEO will become Bpifrance Financement and Bpifrance Investissement will regroup CDC Entreprises, FSI and FSI régions. CDC Entreprises, FSI and FSI Régions will merge to become Bpifrance Investment. | - |
Laurence Pernot | F | 61 | 7 years | |
Franck Silvent | M | 51 |
Banque Publique d'Investissement
Banque Publique d'Investissement Finance/Rental/LeasingFinance Banque Publique Dinvestissement (Bpifrance) is the French Government's public investment institution which was created in 2013 to 'serve the future' by providing financing solutions tailored to each stage of a company's life. Located in Maisons-Alfort, Bpifrance aims to invest EUR 12 billion in French companies by 2017. Their three main tasks are: to help overcome market failures that hamper the financing of enterprises, especially SMEs; to invest in the development of strategic sectors such as digital conversion, environmental and energy, and the social and solidarity economy; and to act as a lever to develop territories in connection with regions in France. Bpifrance includes OSEO, CDC Entreprises, FSI and FSI Regions. OSEO is a public institution whose mission is to support innovation and growth of SMEs. CDC Entreprises is a management company that invests directly or indirectly in SMEs and ETIs at all stages of their development. FSI is an investment fund established by the French government in 2008 to help French companies seeking stable investors to finance their development projects and FSI Régions is a management company which provides regional investment capital. In 2013, OSEO will become Bpifrance Financement and Bpifrance Investissement will regroup CDC Entreprises, FSI and FSI régions. CDC Entreprises, FSI and FSI Régions will merge to become Bpifrance Investment. | - |
Nicolas Yatzimirsky | M | 58 | 24 years | |
Jean-Luc Bélingard | M | 74 |
bioMERIEUX Benelux SANV
bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | 18 years |
Isabelle Boccon-Gibod | F | 55 |
Banque Publique d'Investissement
Banque Publique d'Investissement Finance/Rental/LeasingFinance Banque Publique Dinvestissement (Bpifrance) is the French Government's public investment institution which was created in 2013 to 'serve the future' by providing financing solutions tailored to each stage of a company's life. Located in Maisons-Alfort, Bpifrance aims to invest EUR 12 billion in French companies by 2017. Their three main tasks are: to help overcome market failures that hamper the financing of enterprises, especially SMEs; to invest in the development of strategic sectors such as digital conversion, environmental and energy, and the social and solidarity economy; and to act as a lever to develop territories in connection with regions in France. Bpifrance includes OSEO, CDC Entreprises, FSI and FSI Regions. OSEO is a public institution whose mission is to support innovation and growth of SMEs. CDC Entreprises is a management company that invests directly or indirectly in SMEs and ETIs at all stages of their development. FSI is an investment fund established by the French government in 2008 to help French companies seeking stable investors to finance their development projects and FSI Régions is a management company which provides regional investment capital. In 2013, OSEO will become Bpifrance Financement and Bpifrance Investissement will regroup CDC Entreprises, FSI and FSI régions. CDC Entreprises, FSI and FSI Régions will merge to become Bpifrance Investment. | - |
Estelle Legrand | F | - | 15 years | |
Jean-Pierre Jouyet | M | 70 |
Banque Publique d'Investissement
Banque Publique d'Investissement Finance/Rental/LeasingFinance Banque Publique Dinvestissement (Bpifrance) is the French Government's public investment institution which was created in 2013 to 'serve the future' by providing financing solutions tailored to each stage of a company's life. Located in Maisons-Alfort, Bpifrance aims to invest EUR 12 billion in French companies by 2017. Their three main tasks are: to help overcome market failures that hamper the financing of enterprises, especially SMEs; to invest in the development of strategic sectors such as digital conversion, environmental and energy, and the social and solidarity economy; and to act as a lever to develop territories in connection with regions in France. Bpifrance includes OSEO, CDC Entreprises, FSI and FSI Regions. OSEO is a public institution whose mission is to support innovation and growth of SMEs. CDC Entreprises is a management company that invests directly or indirectly in SMEs and ETIs at all stages of their development. FSI is an investment fund established by the French government in 2008 to help French companies seeking stable investors to finance their development projects and FSI Régions is a management company which provides regional investment capital. In 2013, OSEO will become Bpifrance Financement and Bpifrance Investissement will regroup CDC Entreprises, FSI and FSI régions. CDC Entreprises, FSI and FSI Régions will merge to become Bpifrance Investment. | - |
Paul-François Fournier | M | 56 |
Banque Publique d'Investissement
Banque Publique d'Investissement Finance/Rental/LeasingFinance Banque Publique Dinvestissement (Bpifrance) is the French Government's public investment institution which was created in 2013 to 'serve the future' by providing financing solutions tailored to each stage of a company's life. Located in Maisons-Alfort, Bpifrance aims to invest EUR 12 billion in French companies by 2017. Their three main tasks are: to help overcome market failures that hamper the financing of enterprises, especially SMEs; to invest in the development of strategic sectors such as digital conversion, environmental and energy, and the social and solidarity economy; and to act as a lever to develop territories in connection with regions in France. Bpifrance includes OSEO, CDC Entreprises, FSI and FSI Regions. OSEO is a public institution whose mission is to support innovation and growth of SMEs. CDC Entreprises is a management company that invests directly or indirectly in SMEs and ETIs at all stages of their development. FSI is an investment fund established by the French government in 2008 to help French companies seeking stable investors to finance their development projects and FSI Régions is a management company which provides regional investment capital. In 2013, OSEO will become Bpifrance Financement and Bpifrance Investissement will regroup CDC Entreprises, FSI and FSI régions. CDC Entreprises, FSI and FSI Régions will merge to become Bpifrance Investment. | 11 years |
Connections Chart
Multi-company connection
Former connections
Statistics
Country | Connections | % of total |
---|---|---|
France | 71 | 71.00% |
Belgium | 32 | 32.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Agnès Lemarchand
- Personal Network